• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number DBP-EX-150SOL145
Device Problems Contamination (1120); Off-Label Use (1494)
Patient Problem Obstruction/Occlusion (2422)
Event Date 10/10/2023
Event Type  Injury  
Manufacturer Narrative
H6 investigation conclusion code 22: the diamondback 360® peripheral orbital atherectomy system instructions for use manual states that vessel occlusion is a potential adverse event that may occur and/or require intervention with use of the system.H6 results code: 4247 - suggested code is biological material present on device.The oad was returned for analysis.Analysis revealed adhered biological material on the driveshaft at the crown section.Examination did not reveal any damage that would have contributed to the material accumulation.The morphology and exact root cause of the accumulated biological material was unknown.When tested, the oad functioned as intended.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Csi id: (b)(4).
 
Event Description
The diamondback 360 exchangeable peripheral orbital atherectomy device (oad) was used to treat the superficial femoral artery (sfa).The lesion was an in-stent chronic total occlusion (cto).A single vessel runoff to the anterior tibial artery (at) was observed prior to treatment.After treatment, no dissections were observed, however, the at appeared to be occluded.When observing the crown, biological debris was noticed.The at was re-opened with a balloon and tissue plasminogen activator was administered.The procedure was completed with no further issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer Contact
aaron stevens
1225 old hwy 8 nw
st. paul, MN 55112
MDR Report Key18067409
MDR Text Key327313324
Report Number3004742232-2023-00269
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10852528005831
UDI-Public(01)10852528005831(17)250331(10)481211
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2023
Device Model NumberDBP-EX-150SOL145
Device Catalogue Number7-10030-03
Device Lot Number481211
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-